Skip to main content
Clinical Trials/NCT03810131
NCT03810131
Completed
Not Applicable

Study Protocol for a Feasibility Study of a Novel ACT-based eHealth Psychoeducational Intervention for Students With Mental Distress

Swansea University1 site in 1 country60 target enrollmentJuly 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
A Bite of ACT' (BOA) Acceptance and Commitment Therapy Online Psychoeducation Course
Sponsor
Swansea University
Enrollment
60
Locations
1
Primary Endpoint
Acceptance Checklist for Clinical Effectiveness Pilot Trials (ACCEPT) (Charlesworth, Burnell, Hoe, Orrell, & Russell, 2013)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Here we propose a protocol for assessing the feasibility and acceptability of a randomised controlled trial (RCT) of an online transdiagnostic psychoeducational intervention called 'A Bite of ACT' (BOA) compared to a waitlist control.

Detailed Description

Introduction: Recent studies reveal a high prevalence of depression, anxiety, and stress symptoms among university students, highlighting an urgent need for preventative measures at low cost to better support often overwhelmed support services. Objectives: Here we propose a protocol for assessing the feasibility and acceptability of a randomised controlled trial (RCT) of an online transdiagnostic psychoeducational intervention called 'A Bite of ACT' (BOA) compared to a waitlist control. Methods and analysis: A randomised controlled trial with crossover design will be conducted at baseline, and two follow-up periods. The primary outcome measure will be the ACCEPT checklist, while secondary outcomes include measures of wellbeing, depression, anxiety, and stress (DASS21) and a process measure (psychological flexibility AAQII). Qualitative interviews and preliminary health economics analysis will provide additional insights. Analysis will focus on descriptive statistics and feasibility outcomes and calculate a treatment effect size to determine sample size needed for any future trial (if indicated).

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
November 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Darren Edwards

Principle Investigator

Swansea University

Eligibility Criteria

Inclusion Criteria

  • Participants will be included in the study if they report any feelings of depression, anxiety, and stress (regardless of severity). Participants with an existing psychological disorder will be eligible for the study as long as they are receiving treatment for the disorder and that this treatment does not change over the duration of the study proposed here. Clear instructions will be provided indicating that our BOA intervention should not be used as an alternative to GP/NHS prescribed medication or psychological interventions such as CBT.
  • Participants will need normal or corrected to normal vision and to be able to read and write English.

Exclusion Criteria

  • Participants will be excluded if they do not have mental distress as stated above.
  • Participants will be excluded if they do not have normal or corrected to normal vision and to be able to read and write English.

Outcomes

Primary Outcomes

Acceptance Checklist for Clinical Effectiveness Pilot Trials (ACCEPT) (Charlesworth, Burnell, Hoe, Orrell, & Russell, 2013)

Time Frame: One years (anticipated)

Acceptance Checklist for Clinical Effectiveness Pilot Trials (ACCEPT)

Secondary Outcomes

  • Social connectedness(One years (anticipated))
  • Depression Anxiety Stress Scales(One years (anticipated))
  • EuroQol five dimensions(One years (anticipated))
  • Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)(One years (anticipated))

Study Sites (1)

Loading locations...

Similar Trials